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NucleusCyclin-dependent kinase 5 (Cdk5) is a serine/threonine kinase that has been implicated in a number of cellular
processes. In Dictyostelium, Cdk5 localizes to the nucleus and cytoplasm, interacts with puromycin-sensitive
aminopeptidase A (PsaA), and regulates endocytosis, secretion, growth, and multicellular development.
Here we show that Cdk5 is a calmodulin (CaM)-binding protein (CaMBP) in Dictyostelium. Cdk5, PsaA, and
CaM were all present in isolated nuclei and Cdk5 and PsaA co-immunoprecipitated with nuclear CaM.
Although nuclear CaMBPs have previously been identiﬁed in Dictyostelium, the detection of CaM in puriﬁed
nuclear fractions had not previously been shown. Putative CaM-binding domains (CaMBDs) were identiﬁed
in Cdk5 and PsaA. Deletion of one of the two putative CaMBDs in Cdk5 (132LLINRKGELKLADFGLARAFGIP154)
prevented CaM-binding indicating that this region encompasses a functional CaMBD. This deletion also in-
creased the nuclear distribution of Cdk5 suggesting that CaM regulates the nucleocytoplasmic transport of
Cdk5. A direct binding between CaM and PsaA could not be determined since deletion of the one putative
CaMBD in PsaA prevented the nuclear localization of the deletion protein. Together, this study provides the
ﬁrst direct evidence for nuclear CaM in Dictyostelium and the ﬁrst evidence in any system for Cdk5 being a
CaMBP.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Cyclin-dependent kinase 5 (Cdk5) is a member of a family of
serine/threonine protein kinases and has been shown to function in
a diversity of cellular processes such as axon guidance, membrane
transport, myogenesis, insulin secretion, and lens differentiation
among others [1,2]. Cdk5 dysregulation has been linked to advanced
melanoma and neurodegenerative diseases such as amyotrophic lat-
eral sclerosis and Alzheimer's disease [1,3,4]. Initial characterizations
of Cdk5 focused its cytoplasmic functions however recent studies
have begun to reveal its nuclear functions [5,6]. When NIH3T3 cells
enter the cell cycle, the localization of Cdk5 changes from predomi-
nantly nuclear to cytoplasmic, suggesting that nuclear Cdk5 acts as a
cell cycle suppressor [7]. Cdk5 then returns to the nucleus at the end
of the cell cycle. Cdk5 has also been shown to suppress the cell cycle
in neocortical neurons and to possess a death-promoting functionaMBP, CaM-binding protein;
t kinase 5; PsaA, puromycin-
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rights reserved.within the nucleus of neurons and a pro-survival function when local-
ized to the cytoplasm [8,9].
The Dictyostelium discoideum homologue of mammalian Cdk5 reg-
ulates endocytosis, phagocytosis, and secretion and is required for
the optimal growth, differentiation, and multicellular development
of this model organism [10–12]. Fitting with observations in mam-
mals, the protein localizes to both the nucleus and cytoplasm of
growing cells and translocates from the nucleus to the cytoplasm
during mitosis [12,13]. Cdk5 interacts with puromycin-sensitive ami-
nopeptidase (PsaA) whose function has also been linked to cell prolif-
eration andmitosis inDictyostelium [13,14]. PSAs are highly conserved
metalloproteases that hydrolyze N-terminal amino acids from oligo-
peptides [15]. Inmammals, PSA localizes to both the nucleus and cyto-
plasm and associates with the microtubules of the spindle apparatus
during mitosis [16]. Inhibitors of aminopeptidase activity arrest the
cell cycle and suppress cell proliferation [16–19]. PSA activity has
also shown to be required for meiosis in Arabidopsis thaliana and
Caenorhabditis elegans [20,21].
Calmodulin (CaM) is the primary sensor of calcium (Ca2+) within
the cell and binds to a diversity of CaM-binding proteins (CaMBPs)
that localize throughout the cell in various subcellular compartments
[22–24]. Several CaM-binding motifs that contain either a speciﬁc
positioning of hydrophobic amino acids, a clustering of basic amino
acids, or an IQ or IQ-like motif, have been reported, however not all
CaM-binding motifs have been resolved [25–28]. In addition, some
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[29]. A well-established and accepted method for identifying CaMBPs
and their CaM-binding domains (CaMBDs) involves the deletion of the
putative domain(s), followed by an analysis of whether the deletion
protein can bind CaM [30,31]. In Dictyostelium, CaM localizes predom-
inantly to membranes of the osmoregulatory system (i.e., contractile
vacuole) and has been shown to interact with a number of CaMBPs
[28,32–35]. Using immunoﬂuorescence, a previous study suggested
that CaM also localizes to both the nucleus and cytoplasm but issues of
antibody speciﬁcity and the absence of appropriate controls common
in today's research left these results in question [36]. Like Cdk5 and
PsaA, CaM function in Dictyostelium has also been linked to mitosis
and cell proliferation [33,37]. Nuclear CaMBPs have been identiﬁed in
bothmammalian andDictyostelium cells [28,29,38–40]. InDictyostelium,
the most well studied nuclear CaMBP is NumA, a nucleoplasmic/
nucleolar protein that regulates nuclear number and binds to PsaA
[29,41]. Although nuclear CaM has been studied in mammals, the pres-
ence of CaM in Dictyostelium nuclei has not previously been shown
[28,42,43].
A number of CaM-dependent kinases have been characterized in
mammals and some of these kinases have been shown to localize
and function within the nucleus [44,45]. In HEK293T and PC12 cells,
p35 activity has been shown to be regulated by both CaM-binding
and Cdk5 phosphorylation [46]. Studies inDictyostelium have reported
the CaM-dependent phosphorylation and dephosphorylation of pro-
teins involved in fertilization, germination, and chemotaxis [47–49].
However the identity of the proteins and of the CaM-dependent
kinases and phosphatases has yet to be reported. In this study, co-
immunoprecipitations showed that Cdk5 is a CaMBP in Dictyostelium
and that Cdk5, PsaA, and CaM interact with each other inDictyostelium
nuclei, thus providing the ﬁrst direct evidence for nuclear CaM in this
model organism. Putative CaMBDs were identiﬁed in Cdk5 and PsaA.
The ability of these domains to mediate CaM-binding was assessed
using deletion constructs and co-immunoprecipitations, which ulti-
mately identiﬁed a region in Cdk5 than encompasses a functional
CaMBD.
2. Materials and methods
2.1. Cells and chemicals
All strains were grown either in the presence of Escherichia coli
on SM agar pH 6.5±G418 (100 μg/ml) at 22 °C in the dark for
24–30 h or axenically in HL-5 medium±G418 (10 μg/ml) at 22 °C
and 150 rpm [13]. The following strains were used: AX3 (parental),
AX3/[act15]:cdk5:GFP, AX3/[act15]:cdk5ΔCaMBD1:GFP, AX3/[act15]:
cdk5ΔCaMBD2:GFP, AX3/[act15]:cdk5ΔCaMBD1+2:GFP, AX3/[act15]:
psaA:GFP, AX3/[act15]:psaAΔCaMBD:GFP. W7 was purchased from
Sigma-Aldrich Canada Limited (Oakville, ON, Canada). The QIAquick™
PCR Puriﬁcation Kit, QIAquick™ Gel Extraction Kit, and QIAprep™
Spin Miniprep Kit were used for all PCR puriﬁcations, gel extractions,
and plasmid isolations respectively andwere all purchased fromQiagen
Incorporated (Toronto, ON, Canada). Restriction enzymes were pur-
chased from New England BioLabs Limited (Pickering, ON, Canada). Se-
quence alignments were performed using the dictyBase BLAST server
(http://www.dictybase.org/tools/blast).
2.2. Axenic growth assay
Vegetative cells (1–4×106 cells/ml) grown in HL-5 medium+G418
(10 μg/ml) were diluted to 2×105 cells/ml, transferred to 6-well plates,
and then incubated at 22 °C and 150 rpm. Cell concentrations were
measured every 24 h over a 96 h period using a hemocytometer. In sep-
arate experiments, AX3/[act15]:cdk5:GFP cells (1–2×106 cells/ml)
were grown in HL-5+G418 (10 μg/ml)±the CaM antagonist W7
(50 μM) for 24 h.2.3. Isolation of nuclei
Nuclei were isolated as previously described with minor modiﬁca-
tions [12,13,50–52]. Cells (2×108) in the mid-log phase of growth
(1–5×106 cells/ml) were harvested from HL-5 medium and washed
one time with ice-cold KK2 buffer (2.3 g/l KH2PO4, 1.3 g/l K2HPO4,
pH 6.5). Cells were resuspended in 10 ml of nuclei buffer containing
20 mM Tris–HCl pH 7.4, 5 mM MgOAc, 5% (w/v) sucrose, 0.5 mM
EDTA pH 8.0, 1 mM Na3VO4, 10 mM NaF, 1 μg/ml pepstatin A,
10 μg/ml leupeptin, and a protease inhibitor cocktail (Hoffmann-La
Roche Limited, Mississauga, ON, Canada). Cells were lysed by adding
2 ml of 20% Triton-X and incubating on ice for 10 min. Lysates were
spun at 2000 rpm for 15 min at 4 °C. Supernatants were removed
and retained as non-nuclear (i.e., cytoplasmic) fractions. Pelleted
nuclei were resuspended in 1.5 ml of NP-40 lysis buffer containing
50 mM Tris pH 8.0, 150 mM NaCl, 0.5% NP-40, 5 mM EDTA, 1 mM
Na3VO4, 10 mM NaF, 10 μg/ml leupeptin, 1 μg/ml pepstatin A, and a
protease inhibitor cocktail (Hoffmann-La Roche Limited, Mississauga,
ON, Canada). Samples were sonicated two times for 10 s each to com-
pletely lyse the nuclei and then spun at 12,000 rpm for 10 min at
4 °C. Supernatants were removed and retained as nuclei fractions.
All samples were stored at −80 °C for future use.
2.4. Immunoprecipitation
Immunoprecipitations were performed as previously described
[13]. Rabbit polyclonal anti-Cdk5 (15–25 μl) [13], mouse monoclonal
anti-GFP (green ﬂuorescent protein, 30 μl; Santa Cruz Biotechnology
Inc., Santa Cruz, CA, USA), or mouse monoclonal anti-CaM (5–10 μl;
EMD Chemicals Inc., Gibbstown, NJ, USA) was added to whole cell ly-
sates or nuclei fractions (1–2 mg). Immunoprecipitates were pulled-
down with Immunocruz™ IP resins (B/C/E; 100 μl slurry; Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA). Supernatants were removed
and retained as protein-depleted (PD) fractions. Resins were washed
2–3 times with NP-40 lysis buffer, resuspended in 2× sample loading
buffer, and then boiled for 5 min. Supernatants were removed and
retained as the immunoprecipitate (IP) fraction. Aliquots of IP frac-
tions (e.g. 25 μl)were separated by SDS-PAGE and analyzed byWestern
blotting. Samples were stored at−80 °C for future use.
2.5. SDS-PAGE and Western blotting
SDS-PAGE andWestern blotting were performed as previously de-
scribed [13,53]. The following primary antibodies were used: rabbit
polyclonal anti-Cdk5 (1:400) [13], mouse monoclonal anti-tubulin
(1:1000; 12G10, Developmental Studies Hybridoma Bank, The Univer-
sity of Iowa, IA, USA), rabbit polyclonal anti-PsaA (1:400) [14], mouse
monoclonal anti-GFP (1:1000; Santa Cruz Biotechnology Inc., Santa
Cruz, CA, USA), mouse monoclonal anti-CaM (1:1000; EMD Chemicals
Inc., Gibbstown, NJ, USA), mouse monoclonal anti-phosphotyrosine
and mouse monoclonal anti-phosphothreonine (1:1000; New England
Biolabs Canada, Pickering, ON, Canada). Membranes were developed
with the Amersham™ ECL Plus Western Blotting Detection System
(GE Healthcare, Buckinghamshire, UK) and scanned using a Storm 860
Phosphorimager/Fluorimager (Molecular Dynamics Inc., Sunnyvale, CA,
USA).
2.6. Live cell imaging, ﬁxation, and immunolocalization
Cells in the mid-log phase of growth (1–4×106 cells/ml) were
viewed live after adhering to a coverslip for 30 min. Fixation in
ultra-cold methanol and immunolocalization were performed as pre-
viously described [14]. The following primary and secondary anti-
bodies were used: mouse monoclonal anti-GFP (1:5000; Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA), mouse monoclonal anti-
tubulin (1:100; 12G10, Developmental Studies Hybridoma Bank, The
Fig. 1.Co-immunoprecipitation of Cdk5 andCaM. (A) Cdk5was immunoprecipitated from
AX3 (i) or AX3/[act15]:cdk5:GFP (ii) whole cell lysates with anti-Cdk5. Immunoprecipi-
tates were pulled-down with Immunocruz B™ IP resin. Western blots probed with
anti-CaM or anti-Cdk5. (iii) Incubation of the pull-down resin with a whole cell lysate in
the absence of antibody. Western blot probed with anti-CaM. (B) Effect of Ca2+ and
EGTA on the co-immunoprecipitation of Cdk5 and CaM. Cdk5 was immunoprecipitated
from AX3 (i) or AX3/[act15]:cdk5:GFP (ii) whole cell lysates with anti-Cdk5±EGTA
(5 mM) or CaCl2 (2 mM). Immunoprecipitates were pulled-down with Immunocruz™
B IP resin. Western blots probed with anti-CaM. WC, whole cell lysate (25 μg); IP, immu-
noprecipitate (25 μl); PD, protein-depleted fraction (25 μg); PDF, pull-down fraction
(25 μl aliquot). Molecular weights (in kDa) are indicated in parentheses under each pro-
tein label.
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goat anti-mouse Alexa Fluor™ 555 (1:100; Life Technologies Inc.,
Burlington, ON, Canada). The localization of tubulinwas used to assess
cellular integrity. Prolong™ Gold anti-fade reagent with DAPI (Life
Technologies Inc., Burlington, ON, Canada) was placed on the slide
prior to mounting and coverslips were then sealed using nail polish.
Cells were viewed with a Nikon 50i epiﬂuorescence microscope
equipped with a Nikon Digital-Sight DS-Ri1 camera (Nikon Canada,
Mississauga, ON, Canada) and images were analyzed (e.g., intensity
measurements) using Nikon Imaging Software Elements Basic Re-
search 3.0 (Nikon Canada, Mississauga, ON, Canada). For intensity
measurements, at least one hundred cells were counted per replicate
and at least 4 replicates were performed. The Student's t-test (α=
0.05) was used to calculate signiﬁcance for all graphs. Signiﬁcant dif-
ferences are indicated with an asterisk.
2.7. Generation of GFP expression vectors and cell lines
Vector pDM323, which incorporates C-terminal GFP, was used to
generate all GFP-fusion protein constructs [54]. Full length Cdk5 and
psaA were ampliﬁed from cDNA using the primers CAGAGCTCAAA
ATGGAGAAATATTCAAAA (forward) and CAACTAGTATTAATAGGTTC
TAAACCATCG (reverse) for cdk5 and CAGAGCTCAAAATGTGTAAATA
TAATGATC (forward) and CAACTAGTTTTTTTAATCCAATTTAATAAATC
(reverse) for psaA, which incorporated a Kozak site as well as the ap-
propriate restriction sites (underlined) as previously described [14].
The Cdk5 fragment was incorporated into pDM323 with BglII and
SpeI cut sites. For psaA, a SacI site was inserted into pDM323 between
the BglII and SpeI sites prior to incorporation of the psaA fragment
with SacI and SpeI cut sites. The deletion constructs cdk5ΔCaMBD1-
GFP, cdk5ΔCaMBD2-GFP, cdk5ΔCaMBD1+2-GFP, and psaAΔCaMBD-
GFP were generated in a similar manner, however only the regions
before and after the deletion were ampliﬁed (Table 1). The ampli-
ﬁcation products were ligated together and then ampliﬁed by PCR
using the same primers used to amplify full-length Cdk5 or psaA.
cdk5ΔCaMBD1+2-GFP was generated by amplifying the region be-
fore and after CaMBD2 using cdk5ΔCaMBD1-GFP as a template. Puri-
ﬁed fragments were then incorporated into pDM323 using BglII and
SpeI cut sites for cdk5 constructs and SacI and SpeI cut sites for psaA
constructs. cdk5ΔCaMBD1-GFP and cdk5ΔCaMBD2-GFP possessed a
BamHI and HindIII restriction site, respectively, in place of the
CaMBD, while cdk5ΔCaMBD1+2-GFP possessed a BamHI site in
place of CaMBD1 and a HindIII site in place of CaMBD2. psaAΔCaMBD-
GFP possessed a HindIII site in place of the CaMBD. The constructs
were transformed into AX3 cells as previously described [14]. After
four days of selection, colonies were transferred to HL-5 containing
10 μg/ml G418 within which they were maintained. In total six
strains were generated; AX3/[act15]:cdk5:GFP (encoding Cdk5-GFP),
AX3/[act15]:cdk5ΔCaMBD1:GFP (encoding Cdk5ΔCaMBD1-GFP), AX3/Table 1
List of primers used to generate GFP-fusion CaMBD deletion constructs.
Construct Region before/after deletion For./Rev.
cdk5ΔCaMBDl-GFP Before For.
Rev.
After For.
Rev.
cdk5ΔCaMBD2-GFP Before For.
Rev.
After For.
Rev.
psaAΔCaMBD-GFP Before For.
Rev.
After For.
Rev.
Restriction sites are underlined. For a diagrammatic representation of each GFP-fusion prot[act15]:cdk5ΔCaMBD2:GFP (encoding Cdk5ΔCaMBD2-GFP), AX3/
[act15]:cdk5ΔCaMBD1+2:GFP (encoding Cdk5ΔCaMBD1+2-GFP),
AX3/[act15]:psaA:GFP (encoding PsaA-GFP), and AX3/[act15]:psaA
ΔCaMBD:GFP (encoding PsaAΔCaMBD-GFP).Primers Restriction site
CAGAGCTCAAAATGGAGAAATATTCAAAA BglII
CAGGATCCACCATATGTACCTTC BamHI
CAGGATCCAAAAGAATAAGATTAGACTCTG BamHI
CAACTAGTATTAATAGGTTCTAAACCATCG SpeI
CAGAGCTCAAAATGGAGAAATATTCAAAA BglII
CAAAGCTTATTTTGTGGTTTTAAATCTCTATG HindIII
CAAAGCTTGTTAGAACATATTCACATGAAG HindIII
CAACTAGTATTAATAGGTTCTAAACCATCG SpeI
CAGAGCTCAAAATGTGTAAATATAATGATC SacI
CAAAGCTTACAATATTCACCAACTGATAATTC HindIII
CAAAGCTTAAAGGTGAAGATCGTTATTTAG HindIII
CAACTAGTTTTTTTAATCCAATTTAATAAATC SpeI
ein see Fig. 5.
Fig. 3. Effect of CaM inhibition on the co-immunoprecipitation of Cdk5 and PsaA. AX3/
[act15]:cdk5:GFP cells (1–2×106 cells/ml) were grown in HL-5 medium±W7 (50 μM)
for 24 h. Cdk5-GFP was immunoprecipitated fromwhole cell lysates with anti-GFP. Im-
munoprecipitates were pulled-down with Immunocruz™ C IP resin. Western blots
probed with anti-PsaA or anti-GFP. WC, whole cell lysate (25 μg); IP, immunoprecipi-
tate (25 μl); PD, protein-depleted fraction (25 μg). Molecular weights (in kDa) are indi-
cated in parentheses under each protein label.
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3.1. Co-immunoprecipitation of CaM with Cdk5 and PsaA
Cdk5 was immunoprecipitated from AX3 and AX3/[act15]:cdk5:
GFP whole cell lysates with anti-Cdk5 and the immunoprecipitates
were analyzed by Western blotting with anti-CaM. The ability of
anti-Cdk5 to immunoprecipitate both Cdk5 and Cdk5-GFP was de-
tailed in a previous study and conﬁrmed in this study (Fig. 1Ai,ii)
[13]. CaM was strongly detected in Cdk5 immunoprecipitates from
AX3 and AX3/[act15]:cdk5:GFP whole cell lysates (Fig. 1Ai,ii). To con-
trol for the non-speciﬁc binding of proteins to the pull-down resins, a
whole cell lysate was incubated with the pull-down resin in the ab-
sence of antibody. The pull-down fraction was separated by
SDS-PAGE and analyzed by Western blotting with anti-CaM. CaM
was detected in the whole cell lysate and protein-depleted fraction,
but not in the pull-down fraction (Fig. 1Aiii).
CaM is the primary sensor of Ca2+ within the cell; however binding
of CaM to its CaMBPs can be either Ca2+-dependent or -independent.
To investigate the dependence of Ca2+ on the Cdk5/CaM interaction,
Cdk5 was immunoprecipitated from AX3 whole cell lysates with
anti-Cdk5 in the presence of CaCl2 or the Ca2+ chelator EGTA. In addi-
tion, Cdk5 and Cdk5-GFP were immunoprecipitated from AX3/[act15]:
cdk5:GFP whole cell lysates with anti-Cdk5 in the presence of CaCl2 or
EGTA. CaM was detected in Cdk5 immunoprecipitates from both treat-
ments and both strains (Fig. 1B). To verify the interaction between Cdk5
and CaM, CaM was immunoprecipitated from AX3 and AX3/[act15]:
cdk5:GFP whole cell lysates with anti-CaM. Immunoprecipitates wereFig. 2. Co-immunoprecipitation of CaM, Cdk5, and PsaA. (A) CaM was immuno-
precipitated from AX3 whole cell lysates with anti-CaM±EGTA (5 mM) or CaCl2
(2 mM). Immunoprecipitates were pulled-down with Immunocruz™ C IP resin. Western
blots probed with anti-CaM, anti-PsaA, or anti-Cdk5. (B) CaM was immunoprecipitated
from AX3/[act15]:cdk5:GFP AX3 whole cell lysates with anti-CaM±EGTA (5 mM) or
CaCl2 (2 mM). Immunoprecipitates were pulled-down with Immunocruz™ C IP resin.
Western blots probed with anti-CaM, anti-PsaA, or anti-Cdk5. WC, whole cell lysate
(25 μg); IP, immunoprecipitate (25 μl); PD, protein-depleted fraction (25 μg). Molecular
weights (in kDa) are indicated in parentheses under each protein label.separated by SDS-PAGE and analyzed by Western blotting with anti-
Cdk5. CaM was detected in CaM immunoprecipitates from AX3 and
AX3/[act15]:cdk5:GFP whole cell lysates conﬁrming the pull-down ofFig. 4. Interactions between Cdk5, PsaA, and CaM in isolated nuclei. (A) Subcellular lo-
calization of CaM. Nuclei were isolated from AX3 cells as described in the Materials and
methods section. Protein fractions (25 μg) were separated by SDS-PAGE and analyzed
byWestern blotting with anti-CaM and anti-tubulin (fractionation control). WC, whole
cell lysate; Nuc, nuclei fraction; NN, non-nuclei fraction. (B) Immunoprecipitation of
nuclear CaM. CaM was immunoprecipitated from nuclear fractions with anti-CaM
and immunoprecipitates were pulled-down with Immunocruz™ E IP resin. Western
blots probed with anti-PsaA, anti-Cdk5, or anti-CaM. WC, whole cell lysate (20 μg);
IP, immunoprecipitate (25 μl); PD, protein-depleted fraction (20 μg). (C) CaM was
immunoprecipitated from AX3 whole cell lysates with anti-CaM. Immunoprecipitates
were pulled-down Immunocruz™ E IP resin. Western blots probed with anti-CaM,
anti-phosphotyrosine, or anti-phosphothreonine. WC, whole cell lysate (25 μg); IP,
immunoprecipitate (25 μl); PD, protein-depleted fraction (25 μg). Molecular weights
(in kDa) are indicated in parentheses under each protein label.
Fig. 6. Effect of putative CaMBD deletion on the binding of Cdk5-GFP to CaM.Whole cell
lysates were incubated with anti-GFP or anti-CaM. Immunoprecipitates were pulled-
down with Immunocruz™ B IP resin, separated by SDS-PAGE, and analyzed byWestern
blotting with anti-GFP and anti-CaM. WC, whole cell lysate (20 μg); IP, immunoprecip-
itate (25 μl); PD, protein-depleted fraction (20 μg). Molecular weights (in kDa) are in-
dicated in parentheses under each protein label.
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from AX3 whole cell lysates and there was no effect of CaCl2 or EGTA
on the pull-down (Fig. 2A). In addition, both Cdk5 and Cdk5-GFP were
detected in CaM immunoprecipitates from AX3/[act15]:cdk5:GFP
whole cell lysates with no apparent effect of CaCl2 or EGTA treatment
(Fig. 2B). Like Cdk5, PsaAwas also detected in CaM immunoprecipitates
from AX3 and AX3/[act15]:cdk5:GFP whole cell lysates, with no appar-
ent effect of CaCl2 or EGTA on the pull-down (Fig. 2A,B).
W7, a well-established antagonist of CaM, has previously been used
to inhibit CaM activity in Dictyostelium [55]. Since Cdk5 and PsaA were
shown to co-immunoprecipitate with CaM, the effect of CaM inhibition
on the Cdk5/PsaA interaction was analyzed after a 24 hour axenic
growth period. After 24 h, W7 had inhibited axenic growth by 40–50%,
but did not affect the co-immunoprecipitation of Cdk5-GFP and PsaA
(Fig. 3).
3.2. Interaction between Cdk5, PsaA, and CaM in isolated nuclei
To provide direct evidence for nuclear CaM in Dictyostelium, AX3
cells were fractionated into nuclear and non-nuclear (i.e., cytoplasmic)
fractions, which were then separated by SDS-PAGE and analyzed by
Western blotting with anti-CaM. CaM was detected in both nuclear
and non-nuclear fractions, whereas tubulin, a previously reported con-
trol for nuclear/non-nuclear fractionations, was not (Fig. 4A) [13,56,57].
Since Cdk5, PsaA, CaM have all been shown to localize to the nu-
cleus and since the three proteins co-immunoprecipitate with each
other in whole cell lysates [12–14,58], the interactions between
them in nuclear fractionswas analyzed. CaMwas immunoprecipitated
from AX3 nuclear fractions with anti-CaM. The immunoprecipitates
were separated by SDS-PAGE and analyzed by Western blotting with
anti-Cdk5, anti-PsaA, and anti-CaM. CaMwas detected in immunopre-
cipitates conﬁrming the pull-down of the protein (Fig. 4B). Cdk5 and
PsaA were detected in all fractions, including the immunoprecipitate
(Fig. 4B). Interestingly, two protein bands of molecular weights 33
and 37 kDa were detected on Western blots probed with anti-Cdk5
(Fig. 4B).
A previous study reported the detection of an 18 kDa phospho-
tyrosine protein in Cdk5 and Cdk5-GFP immunoprecipitates [13].
Since CaM was also detected in Cdk5 immunoprecipitates and since
the protein possesses a molecular weight of 18 kDa, the intracellular
phosphorylation of CaM was analyzed. CaM was immunoprecipitated
from AX3 whole cell lysates with anti-CaM and analyzed by Western
blotting with anti-phosphotyrosine and anti-phosphothreonine. AnFig. 5. Domain architecture of Cdk5, PsaA, and GFP-fusion proteins. (A) Location of putative
sitions of putative CaMBDs are indicated. (B) Domain architecture of the GFP-fusion protei18 kDa protein was not detected in CaM immunoprecipitates by either
antibody (Fig. 4C). Anti-phosphotyrosine and anti-phosphothreonine
both detected phosphoproteins onWestern blots of whole cell extracts
(data not shown).
3.3. Identiﬁcation of putative CaMBDs in Cdk5 and PsaA
Since both Cdk5 and PsaA were detected in CaM immunoprecipi-
tates, it was necessary to investigate the ability of these proteins
to bind directly to CaM. Putative CaMBDs were identiﬁed in both
Cdk5 and PsaA using the online CaM Target Database (http://CaMBDs and nuclear localization sequences (NLSs) in Cdk5 and PsaA. Amino acid po-
ns.
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mains were identiﬁed in Cdk5 and one in PsaA (Fig. 5A). The puta-
tive CaMBDs in Cdk5, 17IVYKAKNRETGEIVALK33 (i.e., CaMBD1) and
132LLINRKGELKLADFGLARAFGIP154 (i.e., CaMBD2), were identiﬁed
in the N-terminal and middle regions, respectively, of the Cdk5
amino acid sequence (Fig. 5A). The putative CaMBD in PsaA,
108LSLVFTGLLNDKLKGFYRSKYTV130 (i.e., CaMBD), was identiﬁed in
the N-terminal region of the protein (Fig. 5A). Deletion vectors that
encoded proteins lacking these domains were constructed to investi-
gate the ability of these domains to mediate CaM-binding (Fig. 5B).
The subcellular localization of Cdk5 and PsaA has been investigated
in detail in previous studies [12–14,58]. Since we were also interested
in investigating the effect of domain deletion on the subcellular local-
ization of the proteins, they were tagged with GFP (Fig. 5B).Fig. 7. Effect of putative CaMBD deletion on the localization of Cdk5-GFP. (A) Localization of C
and ﬁxed cells. Cells were stained with DAPI to reveal nuclei. All images shown are represe
bution of Cdk5-GFP, Cdk5ΔCaMBD2-GFP, or Cdk5ΔCaMBD1+2-GFP in live cells. Data prese
analyzed for each replicate. *p-value≤0.05 vs. Cdk5-GFP; **p-value≤0.05 vs. Cdk5-GFP and3.4. Effect of putative CaMBD deletion on the binding of Cdk5-GFP to CaM
and its localization
Proteins were immunoprecipitated from whole cell lysates with
anti-GFP or anti-CaM; however the antibodies did not completely
immunodeplete any of the proteins (Fig. 6). All of the GFP-fusion pro-
teins were detected in GFP immunoprecipitates indicating that they
were all successfully pulled-down (Fig. 6; left panel). CaM was also
successfully pulled-down since it was detected in CaM immunopre-
cipitates (Fig. 6; right panel). Immunoprecipitates were separated
by SDS-PAGE and analyzed by Western blotting with anti-GFP and
anti-CaM. Cdk5ΔCaMBD1-GFP was not detected in any of the frac-
tions that were analyzed (e.g., whole cell, immunoprecipitate, and
protein-depleted) indicating that the proteinwas either not expresseddk5-GFP, Cdk5ΔCaMBD1-GFP, Cdk5ΔCaMBD2-GFP, and Cdk5ΔCaMBD1+2-GFP in live
ntative of a typical cell of that strain. Scale bar=3 μm. (B) Nuclear/cytoplasmic distri-
nted as mean nuclear/cytoplasmic distribution±s.e.m. (n=4). At least 100 cells were
Cdk5ΔCaMBD2-GFP.
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proteins were all expressed and detected at the correct molecular
weight (Fig. 6).
CaM was detected in Cdk5-GFP immunoprecipitates, but not in
Cdk5ΔCaMBD2-GFP or Cdk5ΔCaMBD1+2-GFP immunoprecipitates
(Fig. 6; left panel). To conﬁrm these results, CaM was immunopre-
cipitated from AX3/[act15]:cdk5:GFP, AX3/[act15]:cdk5ΔCaMBD2:GFP,
and AX3/[act15]:cdk5ΔCaMBD1+2:GFP whole cell lysates. Cdk5-GFP
was detected in CaM immunoprecipitates, however Cdk5ΔCaMBD2-
GFP and Cdk5ΔCaMBD1+2-GFP were not (Fig. 6; right panel).
Cdk5-GFP localized to both the nucleus and cytoplasm of live and
ﬁxed cells adhering to previous ﬁndings (Fig. 7A,B) [12,13]. The amount
of Cdk5-GFP in the nucleus was 40±5% higher than the amount in the
cytoplasm (Fig. 7B). No intracellular ﬂuorescence was observed in live
or ﬁxed AX3/[act15]:cdk5ΔCaMBD1:GFP cells, which was consistent
with the inability to detect Cdk5ΔCaMBD1-GFP on Western blots
(Figs. 6,7A). Like Cdk5-GFP, Cdk5ΔCaMBD2-GFP also localized to both
the nucleus and cytoplasmof live andﬁxed cells (Fig. 7A,B). The amount
of Cdk5ΔCaMBD2-GFP in the nucleus was 88±18% higher than in
the cytoplasm,whichwas signiﬁcantly higher than the nuclear distribu-
tion of Cdk5-GFP (p-value≤0.05; Fig. 7B). Cdk5ΔCaMBD1+2-GFP also
localized to both the nucleus and cytoplasm of live and ﬁxed cells, how-
ever the distribution of the protein in the nucleus relative to the cyto-
plasm was signiﬁcantly higher than Cdk5-GFP and Cdk5ΔCaMBD2-
GFP (553±68%; p-value≤0.05; Fig. 7A,B).Fig. 8. Effect of putative CaMBD deletion on the binding of PsaA-GFP to CaM and its localiza
itates were pulled-down with Immunocruz™ B IP resin, separated by SDS-PAGE, and analyz
immunoprecipitate (25 μl); PD, protein-depleted fraction (20 μg). Molecular weights (in kD
and PsaAΔCaMBD-GFP in live and ﬁxed cells. Cells were stained with DAPI to reveal nuclei3.5. Effect of putative CaMBD deletion on the binding of PsaA-GFP to CaM
and its localization
Proteins were immunoprecipitated from whole cell lysates with
anti-GFP or anti-CaM, separated by SDS-PAGE, and analyzed byWest-
ern blotting with anti-GFP and anti-CaM. Anti-GFP and anti-CaM suc-
cessfully pulled-down their target proteins (i.e., GFP-fusion proteins
and CaM respectively) and the GFP-fusion proteins were detected
at the correct molecular weight (Fig. 8A). However, the antibodies
did not completely immunodeplete any of the proteins (Fig. 8A).
CaM was detected in PsaA-GFP immunoprecipitates, but not in PsaA
ΔCaMBD-GFP immunoprecipitates (Fig. 8A; left panel). These results
were veriﬁed by showing that PsaA-GFP could be detected in CaM im-
munoprecipitates, while PsaAΔCaMBD-GFP could not (Fig. 8A; right
panel).
PsaA-GFP localized primarily to the nucleus of live andﬁxed cells ad-
hering to previous ﬁndings (Fig. 8B) [14,58]. Although PsaAΔCaMBD-
GFP could be detected onWestern blots, no intracellular ﬂuorescence
was observed in live or ﬁxed AX3/[act15]:psaAΔCaMBD:GFP cells
(Fig. 8B).
Previous studies have shown that the overexpression of either
PsaA-GFP or Cdk5-GFP in AX3 cells does not affect the rate of cell pro-
liferation [12,14]. In this study, overexpression of PsaAΔCaMBD-GFP,
Cdk5ΔCaMBD1-GFP, Cdk5ΔCaMBD2-GFP, or Cdk5ΔCaMBD1+2-GFP
also had no effect on axenic growth (Fig. 9).tion. (A) Whole cell lysates were incubated with anti-GFP or anti-CaM. Immunoprecip-
ed by Western blotting with anti-GFP and anti-CaM. WC, whole cell lysate (20 μg); IP,
a) are indicated in parentheses under each protein label. (B) Localization of PsaA-GFP
. All images shown are representative of a typical cell of that strain. Scale bar=3 μm.
Fig. 9. Axenic growth of cells over-expressing Cdk5-GFP, PsaA-GFP, or GFP-fusion pro-
teins lacking putative CaMBDs. Vegetative cells (1–4×106 cells/ml) grown in HL-5 me-
dium were diluted to 2×105 cells/ml and then transferred to 6-well plates. Cell
concentrations were measured every 24 h over a 96 hour period. Data presented as
mean concentration±s.e.m. (n=4).
Table 2
Sequence homology between the CaMBDs of Dictyostelium Cdk5 and human Cdk5.
CaMBD Sequence homology
CaMBDI Dicty Cdk5 17IVYKAKNRETGEIVALK33
V+KAKNRET EIVALK
Human Cdk5 17TVFKAKNRETHEIVALK33
CaMBD2 Dicty Cdk5 132LLINRKGELKLADFGLARAFGIP154
LLINR GELKLADFGLARAFGIP
Human Cdk5 132LLINRNGELKLADFGLARAFGIP154
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This study identiﬁed Cdk5 as a CaMBP in Dictyostelium and deter-
mined a region of the protein that is required for CaM-binding. It also
provided the ﬁrst direct evidence for nuclear CaM and revealed new
insight into the nuclear relationship between Cdk5, PsaA and CaM
in this model organism. The results of this study set the stage for fur-
ther research into the function and interaction of nuclear CaMwith its
associated nuclear CaMBPs.
In mammals, p35 function has been shown to be regulated by
CaM-binding and Cdk5 phosphorylation; however a direct binding
between Cdk5 and CaM was not shown [46]. CaM-dependent kinases
have been identiﬁed in mammals and some of these kinases have
been shown to function in the nucleus [44,45]. Previous studies in
Dictyostelium had implicated CaM-dependent phosphorylation and
dephosphorylation in fertilization, germination, and chemotaxis,
however the targeted proteins as well as the proteins and phospha-
tases involved were not identiﬁed [47–49]. In this study, Cdk5 was
identiﬁed as a CaM-dependent kinase that interacts with CaM and
PsaA in Dictyostelium nuclei (Fig. 10).Fig. 10. Interaction of Cdk5 with CaM and PsaA in Dictyostelium nuclei. Cdk5 is a
CaMBP that associates with CaM and PsaA in the nucleoplasm. CaM regulates the
nucleocytoplasmic transport of Cdk5 during mitosis. PsaA also interacts with NumA,
a previously identiﬁed CaMBP that regulates nuclear number.Binding of Cdk5 to CaM occurred both in the presence and absence
of Ca2+ indicating that the bindingwas Ca2+-independent. The region
of amino acids that was deleted in Cdk5ΔCaMBD1-GFP contained
1-10, 1-12, 1-14, and 1-16 hydrophobic motifs. The region deleted in
Cdk5ΔCaMBD2-GFP contained all these motifs as well as a 1-8-14 hy-
drophobic motif. Deletion of CaMBD2 in Cdk5 prevented CaM-binding
indicating that this region encompasses a functional CaMBD (i.e.,
132LLINRKGELKLADFGLARAFGIP154). Since Cdk5ΔCaMBD1-GFP could
not be detected either in cells (i.e., via GFP) or on Western blots, we
cannot rule out the possibility that the deleted region also contains a
functional CaMBD, especially considering that it does possess 1-10,
1-12, 1-14, and 1-16 hydrophobic motifs. However, since Cdk5
ΔCaMBD2-GFP and Cdk5ΔCaMBD1+2-GFP were not able to bind to
CaM, our data conﬁrms that CaMBD2 contains a functional CaMBD.
Interestingly, the two CaMBDs in Dictyostelium Cdk5 are strongly con-
served in human Cdk5 indicating that the interaction between CaM
and Cdk5 in human cells warrants investigation (Table 2).
In Dictyostelium, Cdk5 function has been linked to endocytosis,
phagocytosis, secretion, cell proliferation, cell differentiation, and
multicellular development [10–12]. The protein has also been charac-
terized as a nucleocytoplasmic protein that exits the nucleus during
mitosis, only to return to the nucleus during cytokinesis [13]. Inter-
estingly, the nucleocytoplasmic translocation of Cdk5 has also been
reported to occur in mammalian cells [7]. Deletion of Cdk5 CaMBD2
signiﬁcantly increased the nuclear distribution of the GFP-fusion pro-
tein. This effectwas dramatically enhanced by deletion of both CaMBD1
and CaMBD2. Since Cdk5ΔCaMBD2-GFP and Cdk5ΔCaMBD1+2-GFP
could not bind CaM, and since CaM has been shown to function at
multiple points in the cell cycle and to be required for cell proliferation
in mammals [59,60], these results indicate that CaM may regulate
the nucleocytoplasmic transport of Cdk5, which may ultimately regu-
late mitosis and cell proliferation (Fig. 10). Another interesting ﬁnding
was the detection of two proteins by anti-Cdk5 in nuclear fractions
(33 and37 kDa) suggesting that Cdk5may be post-translationallymod-
iﬁed in the nucleus.
Although both CaM and Cdk5 function have been linked to mitosis
and cell proliferation in Dictyostelium [11–13,33,37], axenic growth
was unaffected by the over-expression of the Cdk5ΔCaMBD-GFP fu-
sion proteins. Axenic growth has also been shown to be unaffected
by the over-expression of Cdk5-GFP [12], indicating that in general,
Dictyostelium may be able to tolerate the overexpression of GFP-
fusion proteins. The non-effect on axenic growth could also be attribut-
ed to the ability of endogenous Cdk5 to still bind CaM. The inability
to detect an 18 kDa phosphotyrosine or phosphothreonine protein in
CaM immunoprecipitates indicates that the unknown phosphotyrosine
protein that was previously identiﬁed in Cdk5 immunoprecipitates was
not CaM [13], that intracellular CaM is not phosphorylated in vivo, and
that CaM is likely not a direct target of Cdk5 kinase activity.
PsaA was detected in CaM immunoprecipitates however a direct
binding of PsaA to CaM could not be conﬁrmed (Fig. 10). PsaA-GFP lo-
calized primarily to the nucleus and was detected in CaM immuno-
precipitates. In contrast, PsaAΔCaMBD-GFP was absent from CaM
immunoprecipitates and could not be localized in either live or ﬁxed
cells. Despite the deleted region in PsaAΔCaMBD-GFP containing 1-10,
1-12, 1-14, 1-16, and 1-5-10 hydrophobic motifs, the absence of PsaA
ΔCaMBD-GFP from CaM immunoprecipitates was likely due to the
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nuclei. Like Cdk5 and CaM, PsaA function has been linked to cell prolif-
eration and mitosis in Dictyostelium [14]. Although PsaA has also been
shown to interact with and co-localize with Cdk5, a previous study
showed that PsaA was not phosphorylated in vivo indicating that the
protein is likely not a target of Cdk5 kinase activity [13]. By treating axe-
nically grown cultures with W7, this study showed that CaM activity is
not required for the Cdk5/PsaA interaction, however it remains to be
determined whether the association between Cdk5 and PsaA is an indi-
rect or a direct interaction.
CaM localizes predominantly to the contractile vacuole in
Dictyostelium, however nuclear and cytoplasmic CaM have also been
reported [32,33,36]. Nuclear CaMBPs have been identiﬁed in both
mammalian and Dictyostelium cells, and while nuclear CaM has been
studied in mammals, nuclear localization of CaM in Dictyostelium
had not previously been conﬁrmed by subcellular fractionation and
Western blotting [28,29,38–40,42,43]. The most well studied nuclear
CaMBP in Dictyostelium NumA regulates nuclear number and binds
PsaA (Fig. 10) [29,41]. By showing that CaM was present in nuclear
fractions of Dictyostelium and that it co-immunoprecipitated with
Cdk5 and PsaA, this study has provided the ﬁrst direct evidence for nu-
clear CaM and has validated previous studies that have characterized
nuclear CaMBPs [29].5. Conclusions
This study is the ﬁrst to identify Cdk5 as a CaMBP in any system.
Since Cdk5, PsaA, and CaM have all been shown to be involved inmedi-
ating cell proliferation in Dictyostelium and since Cdk5 and PsaA exhibit
similar localizations during Dictyosteliummitosis, the data suggest that
these proteins may function as part of a signaling pathway to regulate
cell proliferation in Dictyostelium. The effect of CaMBD deletion on the
nucleocytoplasmic localization of Cdk5 indicates that the Cdk5/CaM in-
teraction is necessary for the proper localization of Cdk5. Together these
ﬁndings set the stage for further research into the function of nuclear
CaM and its associated CaMBPs, the functional details of the Cdk5,
PsaA, and CaM interaction, and the binding of Cdk5 to CaM in other
systems.Acknowledgements
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